Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:subcutaneous tumor incidence/prevalence measurement
go back to main search page
Accession:CMO:0003388 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display subcutaneous tumors at a point in time or develop subcutaneous tumors within a determined period of time are compared to the total number of individuals in the study population, expressed as a percentage or ratio. A subcutaneous tumor is a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive occurring in and composed of cells specific to the hypodermis, lowermost layer of the integumentary system in vertebrates.
Synonyms:exact_synonym: hypodermis tumor incidence/prevalence measurement



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 0
    tumor measurement 0
      tumor incidence/prevalence measurement 0
        subcutaneous tumor incidence/prevalence measurement 0
          percentage of study population developing subcutaneous tumors during a period of time 0
Path 2
Term Annotations click to browse term
  clinical measurement 0
    organ measurement 0
      organ lesion measurement 0
        organ tumorous lesion measurement 0
          organ tumorous lesion incidence/prevalence measurement 0
            tumor incidence/prevalence measurement 0
              subcutaneous tumor incidence/prevalence measurement 0
                percentage of study population developing subcutaneous tumors during a period of time 0
paths to the root